Kim P. Kamdar

CIK 1535065 · last filed 2026-07-14

Kim P. Kamdar is a corporate insider who has filed 41 SEC Form 4 insider transactions across 6 companies since 2015. The most recent filing, for SERA, was dated Jul 14, 2026. Across all open-market trades the lifetime net is +$12.0K, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $111.6K across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$111.6K

Companies

6

Total Filings

41

Lifetime Open-Market Net

$12.0K

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
SERA Director 54,999 $2.03 $111.6K $0 6 2026-07-14
Singular Genomics Systems, Inc. (OMIC) Delisted Director 132,633 $20.01 $2.65M -$362.0K 5 2024-05-31
Evofem Biosciences, Inc. (EVFM) Delisted Director 10 $0.01 $0 $23.0K 8 2022-05-06
Vyome Holdings, Inc (OBLN) Delisted Director 9,049 $9.15 $82.8K $351.0K 9 2020-09-18
Evofem Biosciences, Inc. (NEOT) Delisted Director $0 4 2017-06-22
SNDX Director $19.63 $0 1 2016-11-02

Recent Filings

41 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2026-07-14 SERA Grant (A) +25,847 $0 EDGAR
2026-02-04 SERA Other (J) −27,689 $0 EDGAR
2025-06-06 SERA Grant (A) +15,596 $0 EDGAR
2025-02-25 Disp (D) −3,793,985 $0
2024-06-07 SERA Grant (A) +7,117 $0 EDGAR
2024-05-31 Singular Genomics Systems, Inc. (OMIC) Delisted Grant (A) $0 EDGAR
2023-12-22 Sell (S) −10 -$6
2023-12-14 SERA Notice (144) −17,796 -$89.0K EDGAR
2023-12-14 SERA Notice (144) −2,398,443 -$11.99M EDGAR
2023-08-15 Notice (144) −200,000 -$107.0K EDGAR
Showing 110 of 41
Page 1 of 5
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.